BUZZ-三星生物制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升

路透中文

Yesterday

BUZZ-三星<a href="https://laohu8.com/S/000504">生物</a>制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升

3月12日 - ** 药物制造公司Rapid Micro Biosystems RPID.O股价盘前上涨3%至4.50美元

** 该公司表示，它赢得了三星生物制品公司新的多系统订单，将部署其Growth Direct平台

** Growth Direct可自动进行微生物质量检查，帮助制药商加快生物制剂和疫苗的安全性测试 - RPID

** 该订单扩大了与三星生物制品公司（Samsung Biologics）的现有合作关系，三星生物制品公司是制药行业的主要合同制造商。

** 首席执行官 Robert Spignesi 表示，随着三星扩大生产规模，这些系统将提供更快的结果和更高的准确性

** 2025 年股价上涨约三倍

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2618133226"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618133226\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618133226?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-03-12 18:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618133226","market":"hk","top_or_hot":-1,"title":"BUZZ-三星生物制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-三星<a href=\"https://laohu8.com/S/000504\">生物</a>制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升</title></head><body><p><span>3月12日</span><span> - </span>** 药物制造公司<a href=\"https://laohu8.com/S/RPID\">Rapid Micro Biosystems</a> <span>RPID.O</span>股价盘前上涨3%至4.50美元</p><p>** 该公司表示，它赢得了<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>生物制品公司新的多系统订单，将部署其Growth Direct平台</p><p>** Growth Direct可自动进行微生物质量检查，帮助制药商加快生物制剂和疫苗的安全性测试 - RPID</p><p>** 该订单扩大了与三星生物制品公司（Samsung Biologics）的现有合作关系，三星生物制品公司是制药行业的主要合同制造商。</p><p>** 首席执行官 Robert Spignesi 表示，随着三星扩大生产规模，这些系统将提供更快的结果和更高的准确性</p><p>** 2025 年股价上涨约三倍</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-三星生物制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-三星生物制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-03-12 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-三星<a href=\"https://laohu8.com/S/000504\">生物</a>制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升</title></head><body><p><span>3月12日</span><span> - </span>** 药物制造公司<a href=\"https://laohu8.com/S/RPID\">Rapid Micro Biosystems</a> <span>RPID.O</span>股价盘前上涨3%至4.50美元</p><p>** 该公司表示，它赢得了<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>生物制品公司新的多系统订单，将部署其Growth Direct平台</p><p>** Growth Direct可自动进行微生物质量检查，帮助制药商加快生物制剂和疫苗的安全性测试 - RPID</p><p>** 该订单扩大了与三星生物制品公司（Samsung Biologics）的现有合作关系，三星生物制品公司是制药行业的主要合同制造商。</p><p>** 首席执行官 Robert Spignesi 表示，随着三星扩大生产规模，这些系统将提供更快的结果和更高的准确性</p><p>** 2025 年股价上涨约三倍</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4S4000ZA:1","article_id":"2618133226","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618133226","pubTimestamp":1773311964,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","RPID":"Rapid Micro Biosystems, Inc.","BK4121":"生命科学工具和服务"},"translate_title":"BUZZ-Rapid Micro Biosystems rises as Samsung Biologics orders more automation systems","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RPID":0.9},"content_text":"BUZZ-三星生物制品公司订购更多自动化系统，Rapid Micro 生物系统公司业绩上升3月12日 - ** 药物制造公司Rapid Micro Biosystems RPID.O股价盘前上涨3%至4.50美元** 该公司表示，它赢得了三星生物制品公司新的多系统订单，将部署其Growth Direct平台** Growth Direct可自动进行微生物质量检查，帮助制药商加快生物制剂和疫苗的安全性测试 - RPID** 该订单扩大了与三星生物制品公司（Samsung Biologics）的现有合作关系，三星生物制品公司是制药行业的主要合同制造商。** 首席执行官 Robert Spignesi 表示，随着三星扩大生产规模，这些系统将提供更快的结果和更高的准确性** 2025 年股价上涨约三倍(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}